North America is witnessing significant growth in the recombinant therapeutic protein market due to advanced healthcare infrastructure, strong biotechnology activities, and increasing demand for biologic medicines. The region’s focus on research and development, along with growing adoption of targeted therapies for chronic and complex diseases, is contributing to market expansion.
The...
SPARK Website
English